Ablynx (Belgium)

Ablynx (Belgium)

Ablynx is a subsidiary of biopharmaceutical company Sanofi engaged in the discovery and development of nanobodies, based in Science Park Zwijnaarde, Ghent. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Ablynx (Belgium), Belgium, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

54%


Total
Publications

790


Total Open
Publications

430


Total
Citations

32K


Open Access
Percentage

54%


Total
Publications

790


Total Open
Publications

430


Total
Citations

32K

Wikipedia

Website

download

Breakdown

17% 29% 8% 46%

Publisher Open

17%

Both

29%

Other Platform Open

8%

Closed

46%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

42%OA Journal

OA Journal 42%

151

Hybrid 22%

80

No Guarantees 36%

127

Other Platform Open

Institution 61%

185

Domain 45%

135

Other Internet 24%

74

Preprint 6%

19

Public 2%

5

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
135
Ghent University
Institution
81
DOI
Other Internet
74
Royal Netherlands Academy of Arts and Sciences
Institution
43
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
16
KU Leuven
Institution
16
Université Libre de Bruxelles
Institution
10
arXiv
Preprint
9
Europe PMC
Domain
8
bioRxiv
Preprint
8
1 / 7

Data updated 18 August 2025

Share

Share

Share